Product Description
The global combination console market was valued at $135.7 million in 2025. This is expected to increase over the forecast period at a CAGR of 3.9% to reach $177.7 million.
The full report suite on the global market for combination console is further segmented by resolution standards such as HD and 4K.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Combination Console Market Trends
Combination consoles are commonly sold as part of broader surgical visualization platforms or integrated operating room solutions, which may also include surgical cameras, displays, light sources and operating room (OR) integration software. Hospitals increasingly favor bundled purchasing to simplify procurement, reduce vendor complexity and standardize visualization systems across multiple operating rooms. Bundled sales typically allow facilities to secure package discounts and volume-based pricing, lowering the effective cost per OR compared to purchasing standalone components individually. As a result, combination consoles are frequently positioned as a core component within integrated and bundled visualization offerings, supporting continued market adoption.
Global Combination Console Market Share Insights
- KARL STORZ was the leading competitor in the combination console market in 2025. The company offers TELEPACK+, an all-in-one system that combines monitor, light source, camera control unit and documentation capabilities. TELE PACK+ is compatible with a wide range of rigid, flexible and single-use endoscopes.
- Stryker was the second-leading competitor in the combination console market in 2025, driven by its advanced 4K imaging platforms. The company offers the 1588, 1688 and 1788 Advanced Imaging Platform™, an all-in-one system that integrates a camera control unit, light source and documentation capabilities. The 1788 platform features a 32″ 4K OLED surgical monitor capable of displaying over 1 billion colors, enhancing visualization of fine tissue structures. It includes advanced fluorescence imaging modes, SPY Overlay, SPY Contrast and SPY ENV for improved visualization of perfusion and critical anatomy. The system also incorporates “tone mode” and high dynamic range (HDR) technology to balance brightness and illuminate shadows across the surgical field. Compatible with multiple surgical specialties, the 1788 platform supports seamless integration with Stryker’s Connected OR Hub for enhanced workflow efficiency.
- Arthrex was the third-leading competitor in the combination console market in 2025 due to the company being the first to bring out a combination console in 2015. The company was also the first to bring out a Native 4K imaging platform, which helped Arthrex gain brand recognition. Arthrex’s main combination console product is its Synergy UHD4™ Console.
Global Combination Console Market Segmentation Summary
- HD Combination Console Market
- 4K Combination Console Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
